Trauzold A - Search Results

1

TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma.

Trauzold A, Siegmund D, Schniewind B, Sipos B, Egberts J, Zorenkov D, Emme D, Röder C, Kalthoff H, Wajant H. Trauzold A, et al. Oncogene. 2006 Nov 30;25(56):7434-9. doi: 10.1038/sj.onc.1209719. Epub 2006 Jun 5. Oncogene. 2006. PMID: 16751802

2

The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.

Schäfer H, Trauzold A, Sebens T, Deppert W, Fölsch UR, Schmidt WE. Schäfer H, et al. Among authors: trauzold a. Oncogene. 1998 May 14;16(19):2479-87. doi: 10.1038/sj.onc.1201788. Oncogene. 1998. PMID: 9627114

3

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis.

Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H, Ungefroren H. Hinz S, et al. Among authors: trauzold a. Oncogene. 2000 Nov 16;19(48):5477-86. doi: 10.1038/sj.onc.1203936. Oncogene. 2000. PMID: 11114725

4

CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells.

Trauzold A, Wermann H, Arlt A, Schütze S, Schäfer H, Oestern S, Röder C, Ungefroren H, Lampe E, Heinrich M, Walczak H, Kalthoff H. Trauzold A, et al. Oncogene. 2001 Jul 12;20(31):4258-69. doi: 10.1038/sj.onc.1204559. Oncogene. 2001. PMID: 11464292

5

FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis.

Ungefroren H, Kruse ML, Trauzold A, Roeschmann S, Roeder C, Arlt A, Henne-Bruns D, Kalthoff H. Ungefroren H, et al. Among authors: trauzold a. J Cell Sci. 2001 Aug;114(Pt 15):2735-46. doi: 10.1242/jcs.114.15.2735. J Cell Sci. 2001. PMID: 11683408

6

Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells.

Trauzold A, Schmiedel S, Röder C, Tams C, Christgen M, Oestern S, Arlt A, Westphal S, Kapischke M, Ungefroren H, Kalthoff H. Trauzold A, et al. Br J Cancer. 2003 Nov 3;89(9):1714-21. doi: 10.1038/sj.bjc.6601330. Br J Cancer. 2003. PMID: 14583775 Free PMC article.

7

PKCmu prevents CD95-mediated apoptosis and enhances proliferation in pancreatic tumour cells.

Trauzold A, Schmiedel S, Sipos B, Wermann H, Westphal S, Röder C, Klapper W, Arlt A, Lehnert L, Ungefroren H, Johannes FJ, Kalthoff H. Trauzold A, et al. Oncogene. 2003 Dec 4;22(55):8939-47. doi: 10.1038/sj.onc.1207001. Oncogene. 2003. PMID: 14654790

8

Concerted deregulations of multiple apoptosis-controlling genes in pancreatic carcinoma cells.

Trauzold A, Schmiedel S, Oestern S, Christgen M, Westphal S, Roederm C, Kalthoff H. Trauzold A, et al. Ann N Y Acad Sci. 2003 Dec;1010:510-3. doi: 10.1196/annals.1299.094. Ann N Y Acad Sci. 2003. PMID: 15033781 No abstract available.

9

CD95 and TRAF2 promote invasiveness of pancreatic cancer cells.

Trauzold A, Röder C, Sipos B, Karsten K, Arlt A, Jiang P, Martin-Subero JI, Siegmund D, Müerköster S, Pagerols-Raluy L, Siebert R, Wajant H, Kalthoff H. Trauzold A, et al. FASEB J. 2005 Apr;19(6):620-2. doi: 10.1096/fj.04-2984fje. Epub 2005 Jan 24. FASEB J. 2005. PMID: 15670977

10

Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways.

Schniewind B, Heintz K, Kurdow R, Ammerpohl O, Trauzold A, Emme D, Dohrmann P, Kalthoff H. Schniewind B, et al. Among authors: trauzold a. J Carcinog. 2006 Nov 23;5:25. doi: 10.1186/1477-3163-5-25. J Carcinog. 2006. PMID: 17123441 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page